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The complex role of nitric oxide in the regulation of glomerular lized non-selective blockers of NO synthases (NOS) such
ultrafiltration. Nitric oxide is an important neurohumoral mod- as NG-monomethyl-l-arginine (L-NMMA) and N-nitro-
ulator of glomerular ultrafiltration and renal hemodynamics. l-arginine methyl ester (L-NAME), and have concludedMultiple nitric oxide synthase (NOS) isoforms are present
that blockade of NO in control kidneys results in in-within the kidney. However, it is difficult to discern which
creased vascular resistance and reduction in the glomeru-NOS is most active from prior studies using non-selective NOS
blockers. It is recently apparent that NOS activity is important lar ultra-filtration coefficient [2–5]. Studies from our lab-
to the activity of tubuloglomerular feedback (TGF) systems, oratory have demonstrated that in the kidney these
systems that relate tubular reabsorption to the regulation of consequences are uniquely prevented by blockade of theglomerular ultrafiltration. Neuronal (nNOS) or brain NOS
renin-angiotensin system (RAS) [2], suggesting that one(bNOS; NOS I) is present within the macula densa, the sensing
of the major roles of NO in the kidney is to counteractelement of TGF systems. Inhibition of NOS activity and spe-
cifically bNOS enhances TGF activity. The TGF system also the effects of angiotensin II. Interestingly, the blockade
adapts temporally and these events appear to be dependent of angiotensin II has no effects on the hypertension,
upon up-regulation of activity of bNOS within the kidney.
which occurs following non-selective blockade of NOTemporal adaptation occurs within one to three hours whereby
synthases [2].activation of TGF is followed by a gradual return of the glomer-
ular filtration rate (GFR) and renal blood flow toward normal However, it has become clear that all three subtypes
levels. After 24 hours of benzolamide treatment and with- of NO synthase exist within the kidney: inducible NO
drawal of this agent, glomerular filtration actually increases to synthase (iNOS), endothelial NO synthase (eNOS), and
supranormal levels and this is prevented by inhibition of bNOS
neuronal (or brain) NO synthase (nNOS or bNOS) [6].activity. Factors regulating bNOS activity have not been fully
Therefore, studies utilizing non-selective blockers of NOclarified. We have recently observed N-methyl-d-aspartate
(NMDA) receptors within the kidney that, when inhibited, generating enzymes do not provide specific information
result in major reductions in renal blood flow and GFR, sug- regarding the relative importance of the individual en-
gesting an important role for the NMDA receptor in regulation zymes to these processes. These data also supply noof renal hemodynamics. Future studies will determine whether
specific information as to the regulatory role of physio-NMDA receptor is also an important regulator of bNOS activ-
logic factors that modify the activity of individual NOS,ity and the TGF system.
and certainly have supplied no information as to the
temporal influences on regulation of NOS activity to the
long-term regulation of glomerular ultrafiltration.The regulation of glomerular hemodynamics renal vas-
In the kidney, there is a close coordination betweencular resistances is a complex process that involves the
interplay of multiple neural-humoral factors including the processes of glomerular ultrafiltration and tubular
vasodilators and vasoconstrictors [1]. It has become ap- reabsorption [7]. This is largely achieved by the complex
parent over the last decade that nitric oxide (NO) plays activity of tubuloglomerular feedback (TGF) systems
a unique and important role within the kidney, largely in addition to glomerulotubular balance. Studies from
to buffer out the influences of a variety of potent vaso- several laboratories have established the relevance of
constrictor systems, including angiotensin II and renal TGF systems in the regulation and coordination of a
adrenergic nerves [2–5]. Several publications have uti- variety of renal processes [8]. The TGF system tends to
maintain the relationship between the glomerular filtra-
tion and tubular reabsorption under circumstances inKey words: nitric oxide synthase, tubuloglomerular feedback, NMDA,
receptor, hemodynamics. which there has been either transient reduction in proxi-
mal tubular reabsorption as a result of application of 2002 by the International Society of Nephrology
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to the proximal tubule flow, there is acute activation of
TGF system resulting in a reduction in GFR in that
nephron. Proximal tubular flow rate is monitored by
videometric techniques. Within a period of thirty to sixty
minutes a temporal adaptation of TGF occurs whereby
further vasoconstrictor reserve is “recruited” and re-
established, suggesting that some temporal modification
in the behavior in the TGF system takes place [13, 14].
This could be an important finding for the normal physio-
logic control of kidney function. Similar studies of a
somewhat different design showed that applications of
benzolamide, a carbonic anhydrase inhibitor that de-
creases proximal reabsorption by at least 50%, resultedFig. 1. Effect of L-NMDA (104 mol/L) added to late proximal tubule
on the dependence of single nephron glomerular filtration rate (SNGFR) in an acute activation of feedback systems and the reduc-
on late proximal tubular flow rate (VLP) in open-loop experiments. Each tion of nephron GFR [14, 15]. However, within the pe-
point represents mean SE obtained from 22 to 23 individual nephrons.
riod of 30 to 60 minutes, GFR increased toward normalSymbols are: () control; () L-NMMA; *P  0.05 vs. control.
levels [13, 14]. Certainly within three hours most animals
will exhibit a restoration of normal proximal flow and
GFR [12].
diuretics or tubular injury, or surges in glomerular filtra- In our recent studies, benzolamide was applied on a
tion rate (GFR), which may be the consequence of tran- more chronic basis over a period of twenty-four hours
sient inefficiencies in renal blood flow autoregulation and then withdrawn, and the activity of the TGF system
during increases in blood pressure, or application of va- re-examined [12]. Although this system was initially acti-
sodilator substances. In the past decade, it has been ob- vated by application of this drug, after withdrawal, the
served that NO also plays a significant role in the regula- whole kidney GFR rose to supra-normal levels, as did
tion of the TGF system [9–11]. Several investigators have single nephron GFR. This occurred without any signifi-
shown that application of non-selective blockers of NO cant adaptation in tubular reabsorption within the proxi-
synthases result in accentuation of the activity of TGF, mal tubule or loop of Henle. This hyperfiltration was
magnifying both its vasoconstrictor and vasodilator ca- associated with an up-regulation of bNOS activity as
pacities (Fig. 1) [9–11]. monitored by in situ hybridization assessment of mRNA
The sensing element of the TGF system is thought to and by immunocytochemistry of bNOS in the macula
reside within the macula densa, an adapted distal tubular densa. Most importantly, when inhibitors of bNOS were
cell, which then transmits information from that cell via applied in this model, the TGF systems remained acti-
the extraglomerular mesangium to the glomerular arteri- vated; following withdrawal of benzolamide, GFR re-
oles and the intraglomerular mesangium, resulting in a mained at 30% below normal, and did not exhibit ex-
reciprocal relationship between (a) net sodium chloride aggerated increases or hyperfiltration, suggesting that
transport at the macula densa and (b) blood flow and up-regulation of bNOS activity over this period of time
GFR. NO is not likely the mediator of this communica- is important to the temporal adaptation event [12].
tion system, but it is an important modulator, as is angio- We also examined the first several hours of adaptation
tensin II. Studies have demonstrated that neuronal NOS to TGF following the application of benzolamide (ab-
is located within the macula densa, efferent arteriole, stract; Hammes, J Am Soc Nephrol 11:360A, 2000).
and several other distal tubular cells [6]. Other studies Within a few minutes, renal blood flow and GFR de-
suggested that bNOS, or neuronal NOS, is the major creased by 30 to 40% with the application of this agent
NOS that contributes to modulation of TGF activity [9]. in euvolemic animals. Although the changes in GFR are
These conclusions regarding NO and the TGF system somewhat variable, the GFR returns to normal levels
have been derived primarily from acute, non-steady state within approximately three to four hours. The renal
studies. Studies from our laboratory have suggested that blood flow response is more predictable and renal blood
there are important temporal adaptations of the TGF flow returns to pre-benzolamide levels while the drug is
system following activation by reduction in proximal tu- still active during a period of 60 minutes. In an effort to
bular reabsorption [12–14]. Utilizing on-line videometric determine the neural-humoral mechanisms contributing
velocitometry, we examined behavior of the TGF system to this phenomenon, we concurrently applied angiotensin
in a closed loop system, in which the macula densa is converting inhibitors or S-methyl-thio-citrulline (SMTC),
permitted to communicate directly with the glomerulus a water soluble inhibitor of brain NOS, to determine
in a normal fashion [7]. These on-line studies have dem- the impact of removal of renin-angiotensin activity and
bNOS-derived NO to this process. It is of significantonstrated that if fluid is added at the single nephron level
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interest that the application of angiotensin converting en-
zyme (ACE) inhibitors had no effect, either on the imme-
diate benzolamide TGF response, resulting in vasocon-
striction and lowered GFR or the long-term temporal
adaptation, which still occurred over the same time course
of approximately sixty minutes (abstract; Hammes, J Am
Soc Nephrol 11:360A, 2000). In contradistinction, the
application of SMTC exerted profound effects on the
response to benzolamide. First, the initial vasoconstrictor
response and the reduction in GFR were significantly
magnified by the application of SMTC, the bNOS inhibi-
tor. There was no evidence of temporal adaptation of
TGF over a period of three hours and, therefore, the
renal blood flow and GFR remained reduced. Studies
suggest in the early phases that temporal adaptation is
Fig. 2. Effects of NMDA channel blocker (MK801) and the NMDAalso based upon some activity of bNOS-derived NO.
glycine binding site antagonist (DCKA) on blood flow and during gly-Angiotensin II does not appear to play a significant role
cine infusion in comparison to central responses. Symbols are: ()
in either the acute TGF response or the temporal adapta- baseline; ( ); *P  0.05 vs. baseline; †P  0.05 vs. control value.
tion to this response. Temporal adaptation could be an
important physiological mechanism that may be opera-
tive in such phenomena as the adaptation of sodium
merase chain reaction (RT-PCR) techniques to deter-chloride intake or even in more extreme pathophysio-
mine whether there was NMDA-R present in the kid-logic conditions such as acute tubular injury in renal
ney. A segment common to all NMDA-R receptors wasinflammation and acute renal failure. Our preliminary
used, and we observed a significant PCR band of thestudies provided evidence that following acute renal fail-
appropriate size in each of six rats studied. By sequenc-ure, TGF adaptation does not take place and there is
ing, this product was confirmed to be identical to theno up-regulation of bNOS (unpublished observations).
intended region of the NR-1 gene. Western blots revealedHowever, it is important to determine which influences
NMDA-R NR-1 protein in the rat kidney. Two differentactually determine the changes in bNOS activity within
NMDA-R antagonists were used, one of which blockedthe kidney, and which are the normal regulators.
the glycine binding site and the other blocked the calciumIn neural tissue, especially within the central nervous
channel. It is interesting that both NMDA-R inhibitorssystem, a major regulator of bNOS activity is the NMDA
significantly reduced basal renal blood flow and tendedreceptor [17–19]. The NMDA receptor (NMDA-R) is a
to reduce GFR (Fig. 2). NMDA-R blockade in controlhetero-tetramer amino acid made up of two separate
animals decreased renal blood flow by 36%, and bothproteins, and NMDA-R functions as a membrane cal-
NMDA-R inhibitors significantly attenuated the increasecium channel following activation [20]. This receptor has
in renal blood flow following glycine infusions. As abeen studied extensively in neural tissue where binding
separate control, the renal blood flow in GFR was low-of l-glycine and l-glutamate leads to channel opening
ered by the application of an aortic snare. Under theseand calcium influx enhancing activation of NOS. In neu-
circumstances, glycine responses remained totally intact,ral tissue, this in turn may lead to neuronal cell death
suggesting that this response to glycine was a specificfrom either calcium toxicity or activation of calcium-
effect of the reduction in GFR. These new studies suggestdependent type-1 NO synthase. Little is known, how-
that NMDA-R, a major mechanism for regulation ofever, about NMDA-R outside of the nervous system,
bNOS activity in the brain [16–19], is present in thealthough NMDA-R has been recently reported to stimu-
kidney. Most importantly, NMDA-R blockade, utilizinglate NO release from aortic strips. In addition, systemic
two different inhibitors, produced major reductions ininfusion of l-glycine causes renal vasodilation, which is
renal blood flow and GFR in control animals. Applica-prevented by NOS blockade with non-selective agents.
tion of both inhibitors prevented the increase in renalNOS-1 co-localizes with NMDA-R in the brain and is
blood flow and GFR after the infusion of large dosespersistently expressed in the macula densa cells of the
of l-glycine. Further studies are ongoing to determinekidney, as previously stated (abstract; Deng A, J Am
whether the NMDA-R and bNOS are co-localized withinSoc Nephrol 12:498, 2001) [6]. We have detected the
macula densa cells and whether this constitutes a regula-presence of NMDA-R in the kidney and examined the
tory mechanism activated by amino acids or even poly-effects of NMDA-R antagonists on the renal hemo-
amines to determine overall bNOS activity and bNOSdynamic response to glycine infusion and in the basal
control state. First, we used reverse transcription-poly- expression.
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